首页> 外文期刊>Connective tissue research >Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2
【24h】

Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2

机译:地塞米松,维生素D3,碱性成纤维细胞生长因子和骨形态发生蛋白2培养的人间充质干细胞的成骨分化

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Human mesenchymal stem cells (hMSCs) are pursued for cell-based therapies of bone defects. Successful use of hMSCs will require them to be osteogenically differentiated before transplantation. This study was intended to determine the optimal combination(s) of supplements needed for inducing osteogenesis in hMSCs. Methods: The hMSCs were cultured with combinations of β-glycerophosphate, dexamethasone (Dex), vitamin D3 (Vit-D3), basic fibroblast growth factor (bFGF), and bone morphogenetic protein-2 (BMP-2) to assess cell growth and osteogenesis. Osteogenic responses of the supplements were evaluated by alkaline phosphatase (ALP) activity, mineralization, and gene expression of ALP, Runx2, bone sialoprotein, and osteonectin. Adipogenesis was characterized based on Oil Red O staining, gene expression of peroxisome proliferator-activated receptor γ2, and adipocyte protein-2. Results: Dex was found to be essential for mineralization of hMSCs. Cultures treated with Dex (100 nM), Vit-D3 (10/50 nM), and BMP-2 (500 ng/mL) demonstrated maximal calcification and up-regulation of ALP and bone sialoprotein expression. However, adipogenesis was up-regulated in parallel with osteogenesis in these cultures, as evident by the presence of lipid droplets and significant up-regulation of peroxisome proliferator-activated receptor γ2 and adipocyte protein-2 expression. An optimal condition was obtained at Dex (10 nM) and BMP-2 (500 ng/mL) for mineralization without increasing adipogenesis-related markers. The bFGF mitigated osteogenesis and enhanced adipogenesis. Vit-D3 appears essential for calcification only in the presence of bFGF. Conclusion: Treatment of hMSCs with appropriate supplements at optimal doses results in robust osteogenic differentiation with minimal adipogenesis. These findings could be used in the cultivation of hMSCs for cell-based strategies for bone regeneration.
机译:目的:追求人类间充质干细胞(hMSCs)进行基于细胞的骨缺损治疗。成功使用hMSCs要求在移植前对它们进行成骨分化。这项研究旨在确定诱导hMSCs成骨所需的补充剂的最佳组合。方法:将hMSCs与β-甘油磷酸酯,地塞米松(Dex),维生素D3(Vit-D3),碱性成纤维细胞生长因子(bFGF)和骨形态发生蛋白2(BMP-2)组合培养,以评估细胞的生长和生长。成骨作用。通过碱性磷酸酶(ALP)的活性,矿化作用以及ALP,Runx2,骨唾液蛋白和骨连接蛋白的基因表达来评估补品的成骨反应。根据油红O染色,过氧化物酶体增殖物激活受体γ2的基因表达和脂肪细胞蛋白2表征脂肪形成。结果:发现葡聚糖对于hMSC的矿化至关重要。用Dex(100 nM),Vit-D3(10/50 nM)和BMP-2(500 ng / mL)处理的培养物显示出最大的钙化以及ALP和骨唾液蛋白表达的上调。然而,在这些培养物中,成脂与成骨同时上调,这通过脂质滴的存在以及过氧化物酶体增殖物激活的受体γ2和脂肪细胞蛋白2表达的显着上调来证明。在不增加成脂相关标记的情况下,Dex(10 nM)和BMP-2(500 ng / mL)获得了最佳矿化条件。 bFGF减轻了成骨作用并增强了脂肪形成。 Vit-D3似乎仅在bFGF存在下对钙化至关重要。结论:以最佳剂量用适当的补充剂治疗hMSCs可产生强大的成骨分化能力,且脂肪形成最少。这些发现可用于基于细胞的骨再生策略的hMSC的培养。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号